Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's disease trials. Abanto J, Dwivedi AK, Imbimbo BP, Espay AJ, et al. Brain 2024 Sep 11:awae216. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abanto J, Dwivedi AK, Imbimbo BP, Espay AJ, et al. Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's disease trials. Brain 2024 Sep 11:awae216. doi: 10.1093.
PMID: 39259179